Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ward, J. M.
Right arrow Articles by Devor-Henneman, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ward, J. M.
Right arrow Articles by Devor-Henneman, D. E.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cancer
*Genetics Home Reference
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Mouse Models of Human Familial Cancer Syndromes

Jerrold M. Ward

Veterinary and Tumor Pathology Section, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, USA, jw11by{at}nih.gov

Deborah E. Devor-Henneman

Veterinary and Tumor Pathology Section, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, USA

As many as 5% of human cancers appear to be of hereditable etiology. Of the more than 50 characterized familial cancer syndromes, most involve disease affecting multiple organs and many can be traced to one or more abnormalities in specific genes. Studying these syndromes in humans is a difficult task, especially when it comes to genes that may manifest themselves early in gestation. It has been made somewhat easier with the development of genetically engineered mice (GEM) that phenotypically mimic many of these inheritable human cancers. The past 15 years has seen the establishment of mouse lines heterozygous or homozygous null for genes known or suspected of being involved in human cancer syndromes, including APC, ATM, BLM, BRCA1, BRCA2, LKB1, MEN1, MLH, MSH, NF1, TP53, PTEN, RB1, TSC1, TSC2, VHL, and XPA. These lines not only provide models for clinical disease and pathology, but also provide avenues to investigate molecular pathology, gene-gene and protein-tissue interaction, and, ultimately, therapeutic intervention. Possibly of even greater importance, they provide a means of looking at placental and fetal tissues, where genetic abnormalities are often first detected and where they may be most easily corrected. We will review these mouse models, examine their usefulness in medical research, and furnish sources of animals and references.

Key Words: Mice • cancer • genetics • models • heritable

References

  • Bardeesy, N., Sinha, M., Hezel, A.F., Signoretti, S., Hathaway, N.A., Sharpless, N.E., Loda, M., Carrasco, D.R., and DePinho, R.A. (2002). Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419, 162—7.[CrossRef][Medline] [Order article via Infotrieve]
  • Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J.N., Ried, T., Tagle, D., and Wynshaw-Boris, A. (1996). Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159—71.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Berg, R.J.W., de Vries, A., van Steeg, H., and de Gruijl, F.R. (1997). Relative susceptibilities of XPA knockout mice and their heterozygous and wild-type littermates to UVB-induced skin cancer. Cancer Res 57, 581—4.[Abstract/Free Full Text]
  • Blachford, S. L. (ed). (2002). The Gale Encyclopedia of Genetic Disorders. Detroit, Gale Group, 1345 p.
  • Brannan, C.I., Perkins, A.S., Vogel, K.S., Ratner, N., Norlund, M.L., Reid, S.W., Buchberg, A.M., Jenkins, N.A., Parada, L.F., and Copeland, N.G. (1994). Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 8, 1019—29.[Abstract/Free Full Text]
  • Cai, S., Everitt, J.I., Kugo, H., Cook, J., Kleymenova, E., and Walker, C.L. (2003). Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development. Am J Pathol 162, 457— 68.[Abstract/Free Full Text]
  • Cheung, A.M., Hande, M.P., Jalali, F., Tsao, M-S., Skinnider, B., Hirao, A., McPherson, J.P., Karaskova, J., Suzuki, A., Wakeham, A., You-Ten, A., Elia, A., Squire, J., Bristow, R., Hakem, R., and Mak, T.W. (2002). Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis. Cancer Res 62, 6194—204.[Abstract/Free Full Text]
  • Chester, N., Kuo, F., Kozak, C., O'Hara, C.D., and Leder, P. (1998). Stagespecific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene. Genes Dev 12, 3382—93.[Abstract/Free Full Text]
  • Choyke, P.L., Glenn, G.M., Walther, M.M., Zbar, B., and Linehan, W.M. (2003). Hereditary renal cancers. Radiology 226, 33—46.[Abstract/Free Full Text]
  • Cichowski, K., Shih, T.S., Schmitt, E., Santiago, S., Reilly, K., McLaughlin, M.E., Bronson, R.T., and Jacks, T. (1999). Mouse models of tumor development in neurofibromatosis Type 1. Science 286, 2172—6.[Abstract/Free Full Text]
  • Classon, M., and Harlow, E. (2002). The retinoblastomatumour suppressor in development and cancer. Nature 2, 910—7.
  • Crabtree, J.S., Scacheri, P.C., Ward, J.M., Garrett-Beal, L., Emmert-Buck, M.R., Edgemon, K.A., Lorang, D., Libutti, S.K., Chandrasekharappa, S.C., Marx, S.J., Spiegel, A.M., and Collins, F.S. (2001). A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98, 1118—23.[Abstract/Free Full Text]
  • Crabtree, J.S., Scacheri, P.C., Ward, J.M., McNally, S.R., Swain, G.P., Montagna, C., Hager, J., Hanahan, D., Edlund, H., Magnuson, M.A., Garrett-Beal, L., Burns, A.L., Chandrasekpharappa, S.C., Marx, S.J., Spiegel, A.M., and Collins, F.S. (2003). Of mice and MEN1: insulinomas in a conditional mouse knockout. Mol Cell Biol 23, 6075—85.[Abstract/Free Full Text]
  • Davidson, W.F., Giese, T., and Fredrickson, T.N. (1998). Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. J Exp Med 187, 1825—38.[Abstract/Free Full Text]
  • Deng, C.-X. (2001). Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice. Mutat Res 477, 183—89.[Web of Science][Medline] [Order article via Infotrieve]
  • Deng, C.-X., Brodie, S.G. (2001). Knockout mouse models and mammary tumorigenesis. Cancer Biol 11, 387—94.[CrossRef]
  • de Vries, A., van Oostrom, C.T.M., Dortant, P.M., Beems, R.B., van Kreijl, C.F., Capel, P.J.A., and van Steeg, H. (1997). Spontaneous liver tumors and benzo[{alpha}]pyrene-induced lymphomas in XPA-deficient mice. Mol Carcinog 19, 46—53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • de Vries, A., van Oostrom, C.T., Hofhuis, F.M., Dortant, P.M., Berg, R.J., de Gruijl, F.R., Wester, P.W., van Kreijl, C.F., Capel, P.J., van Steeg, H., et al. (1995 ). Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 377, 169—73.[CrossRef][Medline] [Order article via Infotrieve]
  • de Vries, A., and van Steeg, H. (1996). Xpa knockout mice. Cancer Biol 7, 229—40.[CrossRef]
  • de Wind, N., Dekker, M., Berns, A., Radman, M., and te Riele, H. (1995). Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82, 321—30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, Jr., C.A., Butel, J.S., and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215—21.[CrossRef][Medline] [Order article via Infotrieve]
  • Donehower, L.A., Harvey, M., Vogel, H., McArthur, M.J., Montgomery, Jr., C.A., Park, S.H., Thompson, T., Ford, R.J., and Bradley, A. (1995). Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog 14, 16—22.[Web of Science][Medline] [Order article via Infotrieve]
  • Edelmann, W., Umar, A., Yang, K., Heyer, J., Kucherlapati, M., Lia, M., Kneitz, B., Avdievich, E., Fan, K., Wong, E., Crouse, G., Kunkel, T., Lipkin, M., Kolodner, R.D., and Kucherlapati, R. (2000). The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression. Cancer Res 60, 803—7.[Abstract/Free Full Text]
  • Edelmann, W., Yang, K., Kuraguchi, M., Heyer, J., Lia, M., Kneitz, B., Fan, K., Brown, A.M.C., Lipkin, M., and Kucherlapati, R. (1999). Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice. Cancer Res 59, 1301—7.[Abstract/Free Full Text]
  • Fearon, E.R., and Gruber, S.B. (2001). Molecular abnormalities in colon and rectal cancer. In The Molecular Basis of Cancer, second edition (Mendelsohn, J., Howley, P. M., Israel, M. A., Liotta, L. A., eds.), pp. 289—312. Phila: WB Saunders Co.
  • Fitzpatrick, G.V., Soloway, P.D., and Higgins, M.J. (2002). Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nature Genet 32, 426—31.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • French, J., Storer, R.D., and Donehower, L.A. (2001). The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens. Toxicol Pathol 29, 24—9.[Abstract/Free Full Text]
  • Ghebranious, N., and Donehower, L.A. (1998). Mouse models in tumor suppression. Oncogene 17, 3385—3400.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Giovannini, M., Robanus-Maandag, E., Niwa-Kawakita, M., van der Valk, M., Woodruff J.M., Goutebroze, L., Merel, P., Berns, A., and Thomas, G. (1999). Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev 13, 978—86.[Abstract/Free Full Text]
  • Giovannini, M., Robanus-Maandag, E., van der Valk, M., Niwa-Kawakita, M., Abramowski, V., Goutebroze, L., Woodruff, J.M., Berns, A., and Thomas, G. (2000). Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14, 1617—30.[Abstract/Free Full Text]
  • Girnun, G.D., Smith, W.M., Drori, S., Sarraf, P., Mueller, E., Eng, C., Nambiar, P., Rosenberg, D.W., Bronson, R.T., Edelmann, W., Kucherlapati, R., Gonzalez, F.J., and Spiegelman, B.M. (2002). APC-dependent suppression of colon carcinogenesis by PPAR{gamma}. Proc Natl Acad Sci USA 99, 13771—6.[Abstract/Free Full Text]
  • Goodrich, L.V., Milenkovic, L., Higgins, K.M., and Scott, M.P. (1997). Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109—13.[Abstract/Free Full Text]
  • Guru, S.C., Crabtree, J.S., Brown, K.D., Dunn, K.J., Manickam, P., Prasad, N.B., Wangsa, D., Burns, A.L., Spiegel, A.M., Marx, S.J., Pavan, W.J., Collins, F.S., and Chandrasekharappa, S.C. (1999). Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene. Mamm Genome 10, 592—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Haase, V.H., Glickman, J.N., Socolovsky, M., and Jaenisch, R. (2001). Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci USA 98, 1583—8.[Abstract/Free Full Text]
  • Harvey, M., McArthur, M.J., Montgomery, Jr., C.A., Bradley, A., and Donehower, L.A. (1993). Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J 7, 938—43.[Abstract]
  • Herzer, U., Crocoll, A., Barton, D., Howells, N., and Englert, C. (1999). The Wilms tumor suppressor gene wt1 is required for the development of the spleen. Curr Biol 9, 837—40.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Heyer, J., Yang, K., Lipkin, M., Edelmann, W., and Kucherlapati, R. (1999). Mouse models for colorectal cancer. Oncogene 18, 5325—33.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hu, N., Gutsmann, A., Herbert, DC, Bradley, A., Lee, W.-H., and Lee, Ey.-Hp. (1999). Heterozygous Rb-1{Delta}20 /+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9, 1021—7.
  • Hursting, S.D., Perkins, S.N., Phang, J.M., and Barrett, J.C. (2001). Diet and cancer prevention studies in p53-deficient mice. J Nutr 131, 3092S—4S.[Abstract/Free Full Text]
  • Jacks, T., Fazeli, A., Schmitt, E.M., Bronson, R.T., Goodell, M.A., and Weinberg, R.A. (1992). Effects of an Rb mutation in the mouse. Nature 359, 295—300.[CrossRef][Medline] [Order article via Infotrieve]
  • Jacks, T., Shih, T.S., Schmitt, E.M., Bronson, R.T., Bernards, A., and Weinberg, R.A. (1994). Tumor predisposition in mice heterozygous for a targeted mutation in Nf1 Nat Genet 7, 353—61.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jacoby, R.F., Seibert, K., Cole, C.E., Kelloff, G., and Lubet, R.A. (2000). The cyclooxygenase-2 inhibbitor Celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 60, 5040—4.[Abstract/Free Full Text]
  • Jishage, K., Nezu, J., Kawase, Y., Iwata, T., Watanabe, M., Miyoshi, A., Ose, A., Habu, K., Kake, T., Kamada, N., Ueda, O., Kinoshita, M., Jenne, DE, Shimane, M., and Suzuki, H. (2002). Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis. Proc Natl Acad Sci USA 99, 8903—8.[Abstract/Free Full Text]
  • Kalamarides, M., Niwa-Kawakita, M., Leblois, H., Abramowski, V., Perricaudet, M., Janin, A., Thomas, G., Gutmann, D.H., and Giovannini, M. (2002). Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev 16, 1060—5.[Abstract/Free Full Text]
  • Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. (1993). WT-1 is required for early kidney development. Cell 74, 679—91.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kucherlapati, R., Lin, D.P., and Edelmann, W. (2001). Mouse models for human familial adenomatous polyposis. Cancer Biol 11, 219—25.[CrossRef]
  • Kuperwasser, C., Hurlbut, G.D., Kittrell, F.S., Dickinson, E.S., Laucirica, R., Medina, D., Naber, S.P., and Jerry, D.J. (2000). Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome. Am J Pathol 157, 2151—9.[Abstract/Free Full Text]
  • Kwiatkowski, D.J., Zhang, H., Bandura, J.L., Heiberger, K.M., Glogauer, M., el- Hashemite, N., and Onda, H. (2002). A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet 11, 525—34.[Abstract/Free Full Text]
  • Kwon, C.-H., Zhu, X., Zhang, J., Knoop, L.L., Tharp, R., Smeyne, R.J., Eberhart, C.G., Burger, P.C., and Baker, S.J. (2001). Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29, 404—11.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Largaespada, D.A., Brannan, C.I., Jenkins, N.A., and Copeland, N.G. (1996). Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. Nat Genet 12, 137—43.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lee, E.Y.-H.P., Chang, C.-Y., Hu, N., Wang, Y.-C.J., Lai, C.-C., Herrup, K., Lee, W.-H., and Bradley, A. (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288— 94.[CrossRef][Medline] [Order article via Infotrieve]
  • Li, G., Robinson, G.W., Lesche, R., Martinez-Diaz, H., Jiang, Z., Rozengurt, N., Wagner, K.-U., Wu, D.-C., Lane, T.F., Liu, X., Hennighausen, L., and Wu, H. (2002). Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 129, 4159— 70.[Abstract/Free Full Text]
  • Lombard, D.D., Beard, C., Johnson, B., Marciniak, R.A., Dausman, J., Bronson, R., Buhlmann, J.E., Lipman, R., Curry, R., Sharpe, A., Jaenisch, R., and Guarente, L. (2000). Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol 20, 3286—91.[Abstract/Free Full Text]
  • Ludwig, T., Chapman, D.L., Papaioannou, V.E., and Efstratiadis, A. (1997). Targeted mutations of breast cancer susceptibility gene homologs I mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev 11, 1226—41.[Abstract/Free Full Text]
  • Ludwig, T., Fisher, P., Ganesan, S., and Efstratiadis, A. (2001). Tumorigenesis in mice carrying a truncating Brca1 mutation. Genes Dev 15, 1188—93.[Abstract/Free Full Text]
  • Ludwig, T., Fisher, P., Murty, V., and Efstratiadis, A. (2001). Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice. Oncogene 20, 3937—48.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Luo, G., Santoro, I.M., McDaniel, L.D., Nishijima, I., Mills, M., Youssoufian, H., Vogel, H., Schultz, R.A., and Bradley, A. (2000). Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet 26, 424—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lynch, H.T., and de la Chapelle, A. (2003). Hereditary colorectal cancer. N Engl J Med 348, 919—32.[Free Full Text]
  • Ma, W., Tessarollo, L., Hong, S.-B., Baba, M., Southon, E., Back, T.C., Spence, A., Lobe, C.G., Sharma, N., Maher, G.W., Pack, S., Vortmeyer, A.O., Guo, C., Zbar, B., and Schmidt, L.S. (2003). Hepatic vascular tumors, angiectasis in multiple organs and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. Cancer Res 63, 5320—28.[Abstract/Free Full Text]
  • MacPherson, D., Sage, J., Crowley, D., Trumpp, A., Bronson, R.T., and Jacks, T. (2003). Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol Cell Biol 23, 1044— 53.[Abstract/Free Full Text]
  • Mai, V., Colbert, L.H., Berrigan, D., Perkins, S.N., Pfeiffer, R., Lavigne, J.A., Lanza, E., Haines, D.C., Schatzkin, A., and Hursting, S.D. (2003). Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in ApcMin mice through different mechanisms. Cancer Res 63, 1752—5.[Abstract/Free Full Text]
  • Marino, S., Krimpenfort, P., Leung, C., van der Korput, H.A.G.M., Trapman, J., Camenisch, I., Berns, A., and Brandner, S. (2002). PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development 129, 3513—22.[Web of Science][Medline] [Order article via Infotrieve]
  • McAllister, K.A., Bennett, L.M., Houle, C.D., Ward, T., Malphurs, J., Collins, N.K., Cachafeiro, C., Haseman, J., Goulding, E.H., Bunch, D., Eddy, E.M., Davis, B.J., and Wiseman, R.W. (2002). Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene. Cancer Res 62, 990—4.[Abstract/Free Full Text]
  • McClatchey, A.I., Saotome, I., Mercer, K., Crowley, D., Gusella, J.F., Bronson, R.T., Jacks, T. (1998). Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 12, 1121—33.[Abstract/Free Full Text]
  • McClatchey, A.I., Saotome, I., Ramesh, V., Gusella, J.F., and Jacks, T. (1997). The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev 11, 1253—65.[Abstract/Free Full Text]
  • Mendelsohn, J. (Ed) (2001 ). The Molecular Basis Of Cancer, Second edition, Philadelphia, Saunders, 691 p.
  • Miyoshi, H., Nakau, M., Ishikawa, T.O., Seldin, MF, Oshima, M., and Taketo, M.M. (2002). Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res 62, 2261—6.[Abstract/Free Full Text]
  • Moynahan, M.E. (2002). The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. Oncogene 21, 8994—9007.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nakane, H., Takeuchi, S., Yuba, S., Saijo, M., Nakatsu, Y., Murai, H., Nakatsuru, Y., Ishikawa, T., Hirota, S., Kitamura, Y., Kato, Y., Tsunoda, Y., Miyauchi, H., Hrio, T., Tokunaga, T., Matsunaga, T., Nikaido, O., Nishimune, Y., Okada, Y., Tanaka, K., et al. (1995). High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature 377, 165—8.[CrossRef][Medline] [Order article via Infotrieve]
  • Nakau, M., Miyoshi, H., Seldin, M.F., Imamura, M., Oshima, M., and Taketo, M.M. (2002) Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res 62, 4549—53.[Abstract/Free Full Text]
  • Nikitin, A.Y., Juárez-Pàrez, M.I., Li, S., Huang, L., and Lee, W.-H. (1999). RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in RB+/- mice. Proc Natl Acad Sci USA 96, 3916—21.[Abstract/Free Full Text]
  • Nikitin, A.Y., and Lee, W.-H. (1996). Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice. Genes Dev 10, 1870—9.[Abstract/Free Full Text]
  • Nikitin, A.Y., Liu, C.-Y., Flesken-Nikitin, A., Chen, C.-F., Chen, P.-L., and Lee, W.-H. (2002). Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2-/- RB+/- mice. Cancer Res 62, 5134—8.[Abstract/Free Full Text]
  • Nussbaum, R.L., McInnes, R.R., and Willard, H.F. (2001). Thompson & Thompson Genetics in Medicine, 6th Edition. W.B. Saunders, Philadelphia, 444 pp.
  • Onda, H., Lueck, A., Marks, P.W., Warren, H.B., and Kwiatkowski, D.J. (1999). Tsc2+/- mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest 104, 687—95.[Web of Science][Medline] [Order article via Infotrieve]
  • Orner, G.A., Dashwood, W.M., Blum, C.A., Diaz, G.D., Li, Q., and Dashwood, R.H. (2003). Suppression of tumorigenesis in the ApcMin mouse: down regulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 24, 263—7.[Abstract/Free Full Text]
  • Oshima, M., Dinchuk, J.E., Kargman, S.L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J.M., Evans, J.F., and Taketo, M.M. (1996). Suppression of intestinal polyposis in Apc{Delta}716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Phillips, R.K.S., Wallace, M.H., Lynch, P.M., Hawk, E., Gordon, G.B., Saunders, B.P., Wakabayashi, N., Shen, Y., Zimmerman, S., Godio, L., Rodriguez-Bigas, M., Su, L.-K., Sherman, J., Kelloff, G., Levin, B., and Steinbach, G. (2002). A randomized, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 50, 857—60.[Abstract/Free Full Text]
  • Podsypanina, K., Ellenson, L.H., Nemes, A., Gu, J., Tamura, M., Yamada, K.M., Cordon-Cardo, C., Catoretti, G., Fisher, P.E., and Parsons, R. (1999). Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 96, 1563—8.[Abstract/Free Full Text]
  • Purdie, C.A., Harrison, D.J., Peter, A., Dobbie, L., White, S., Howie, S.E.M., Salter, D.M., Bird, C.C., Wyllie, A.H., Hooper, M.L., and Clarke, A.R. (1994). Tumor incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9, 603—9.[Web of Science][Medline] [Order article via Infotrieve]
  • Reitmair, A.H., Schmits, R., Ewel, A., Bapat, B., Redston, M., Mitri, A., Waterhouse, P., Mittrucker, H.-W., Wakeham, A., Liu, B., Thomason, A., Griesser, H., Gallinger, S., Ballhausen, W.G., Fishel, R., and Mak, T.W. (1995). MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 11, 64—70.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Riley, D.J., Nikitin, A.Y., and Lee, W.-H. (1996). Adenovirus-mediated retinoblastoma gene therapy suppresses spontaneous pituitary melanotroph tumors in Rb+/- mice. Nat Med 2, 1316—21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Seno, H., Oshima, M., Ishikawa, T.O., Oshima, H., Takaku, K., Chiba, T., Narumiya, S., and Taketo, M.M. (2002). Cyclooxygenase2-and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res 62, 506—11.[Abstract/Free Full Text]
  • Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R.A. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27—37.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sharp, Z.D., Lee, W.-H., Nikitin, A.Y., Flesken-Nikitin, A., Ikeno, Y., Reddick, R., Richardson, A.G., and Nelson, J.F. (2003). Minimal effects of dietary restriction on neuroendocrine carcinogenesis in Rb+/- mice. Carcinogenesis 24, 179—83.[Abstract/Free Full Text]
  • Sharpless, N.E., Alson, S., Chan, S., Silver, D.P., Castrillon, D.H., and DePinho, R.A. (2002). P16INK4a and p53 deficiency cooperate in tumorigenesis. Cancer Res 62, 2761—5.[Abstract/Free Full Text]
  • Spring, K., Ahangari, F., Scott, S.P., Waring, P., Purdie, D.M., Chen, P.C., Hourigan, K., Ramsay, J., McKinnon, P.J., Swift, M., and Lavin, M.F. (2002). Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat Genet 32, 185—90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Spring, K., Cross, S., Li, C., Watters, D., Ben-Senior, L., Waring, P., Ahangari, F., Lu, S., Chen, P., Misko, I., Paterson, C., Kay, G., Smorodinsky, N.I., Shiloh, Y., and Lavin, M.F. (2001). Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res 61, 4561—8.[Abstract/Free Full Text]
  • Su, L.-K., Kinzler, K.W., Vogelstein, B., Preisinger, A.C., Moser, A.R., Luongo, C., Gould, K.A., and Dove, W.F. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668—70.[Abstract/Free Full Text]
  • Suzuki, A., Itami, S., Ohishi, M., Hamada, K., Inoue, T., Komazawa, N., Senoo, H., Sasaki, T., Takeda, J., Manabe, M., Mak, T.W., and Nakano, T. (2003). Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res 63, 674—81.[Abstract/Free Full Text]
  • Tonelli, F., Valanzano, R., Messerini, L., and Ficari, F. (2000). Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer? J Surg Oncol 74, 15—20.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Uhlmann, E.J., Apicelli, A.J., Baldwin, R.L., Burke, S.P., Bajenaru, M.L., Onda, H., Kwiatkowski, D., and Gutmann, D.H. (2002). Heterozygosity forthe tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells. Oncogene 21, 4050—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Vogel, K.S., Klesse, L.J., Velasco-Miguel, S., Meyers, K., Rushing, E.J., and Parada, L.F. (1999). Mouse tumor model for neurofibromatosis Type 1. Science 286, 2176—9.[Abstract/Free Full Text]
  • Vogelstein, B., and Kinzler, K. W. (eds.) (2002). The Genetic Basis of Human Cancer, 2nd Edn. New York, McGraw-Hill, 821 p.
  • Vooijs, M., and Berns, A. (1999). Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 18, 5293—303.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wagner, K.D., Wagner, N., Vidal, V.P., Schley, G., Wilhelm, D., Schedl, A., Englert, C., and Scholz, H. (2002). The Wilms' tumor gene Wt1 is required for normal development of the retina. EMBO J 21, 1398— 1405.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wang, H., Douglas, W., Lia, M., Edelmann, W., Kucherlapati, R., Podsypanina, K., Parsons, R., and Ellenson, L.H. (2002). DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice. Am J Pathol 160, 1481—6.[Abstract/Free Full Text]
  • Ward, J.M. (2002). Preneoplastic and precancerous lesions in rodents: morphologic and molecular characteristics. J Toxicol Pathol 15, 123—8.[CrossRef]
  • Wei, K., Kucherlapati, R., and Edelmann, W. (2002). Mouse models for human DNA mismatch-repair gene defects. Trends Molec Med 8, 346—53.[CrossRef]
  • Williams, B.O., Remington, L., Albert, D.M., Mukai, S., Bronson, R.T., and Jacks, T. (1994). Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7, 480—4.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Yang, Y., Kuang, Y., De Oca, R.M., Hays, T., Moreau, L., Lu, N., Seed, B., and D'Andrea, A.D. (2001). Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood 98, 3435—40.[Abstract/Free Full Text]
  • Zbar, B., Klausner, R., and Linehan, WM (2003). Studying cancer families to identify kidney cancer genes. Annu Rev Med 54, 217—33.[CrossRef][Medline] [Order article via Infotrieve]
  • Zhu, Y., and Parada, L.F. (2002). The molecular and genetic basis of neurological tumours. Nature 2, 616—26.
  • Zhu, Y., Ghosh, P., Charnay, P., Burns, D.K., and Parada, L.F. (2002). Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296, 920—2.[Abstract/Free Full Text]
  • Zurawel, R.H., Allen, C., Wechsler-Reya, R., Scott, M.P., and Raffel, C. (2000). Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice. Genes Chromosomes Cancer 28, 77—81.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 32, No. 1 suppl, 90-98 (2004)
DOI: 10.1080/01926230490424680
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ward, J. M.
Right arrow Articles by Devor-Henneman, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ward, J. M.
Right arrow Articles by Devor-Henneman, D. E.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cancer
*Genetics Home Reference
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?